ANNX FY 2018 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$706M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$488,000

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-1.60

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$408,000

Balance Sheet

Total Assets

$48M

Total Liabilities

$10M

Stockholders' Equity

$38M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$488,000	-$271,000	-80.1%
Operating Income	-$19M	-$20M	+6.5%
Net Income	-$18M	-$19M	+2.2%